This $601,496 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the University of Rochester to investigate the mechanisms behind the development of neurological disorders caused by exposure to airborne hazards. The research aims to provide mechanistic insights that can lead to improved prevention and treatment of these types of disorders. The performance period for this award runs from...
The University of Rochester was awarded a $1,829,300 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the mechanistic links between airborne hazards exposure and the development of neurological disorders. The award, which began on August 1, 2024 and is scheduled for completion by July 31, 2027, will enable the university to gain deeper insights into the biological processes underlying the impact of...
This $848,248 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research to adapt behavioral activation interventions to improve mental health outcomes and reduce suicide risk during the military transition. The award to Research Triangle Institute (RTI International), a non-profit research organization, will fund a 3-year project from August 2024 to July 2027 to develop and evaluate an evidence-based...
The Defense Health Agency awarded Trustees of Dartmouth College a $2,031,453 project grant under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop machine learning strategies for predicting suicide risk using clinical note text from May 1, 2023 to April 30, 2026. Dartmouth College will utilize subawards to Cedars-Sinai Medical Center, Vanderbilt University Medical Center, and Veterans Education And Research Association Of Northern New England, Inc....
The University of Rochester received a $2,482,055 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to enhance the First-Line Leader Program for the Idaho Army National Guard. The goal of this 4-year project is to reduce crises and suicide within the Idaho Army National Guard through research and interventions targeting first-line leaders. The University of Rochester, as a leading academic institution with expertise in...
The federal Project Grant award ID HT94252410796, titled "ARMY-SUICIDE PREVENTION: RESEARCH ON THE IMPLEMENTATION IN THE NATIONAL GUARD (ARMY-SPRING)", is funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The $240,894 award, effective September 1, 2024 through August 31, 2028, will support research conducted by Yale University to investigate the implementation of suicide prevention strategies within the National Guard. The...
This $655,135 federal Project Grant, awarded on June 1, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the development of a computerized screening and brief intervention for interpersonal violence among active-duty service members. The award recipient, Rhode Island Hospital, a division of Lifespan Corporation, will leverage its clinical expertise and research capabilities to conduct this 3-year project addressing this...
The Defense Health Agency awarded Syracuse University a $1,099,513 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to develop antimicrobial shape memory polymer foams for rapid hemorrhage control and infection prevention in traumatic wounds. The grant period runs from August 15, 2023 to August 14, 2026. The research aims to transform health care for Service Members and the American public through innovative and impactful biomedical research focused on...
This federal Project Grant award for $6,292,954.00 was issued on September 30, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The funding supports the "Monitoring and Mitigation of Neurological Injuries to Optimize Resilience After Repetitive Head Impacts" (MONITOR RHI) research project.
The primary awardee, the University of Rochester, will conduct scientific studies to develop treatments and interventions to address...
The Defense Health Agency awarded a $250,000 Project Grant to Rutgers, The State University of New Jersey to conduct research titled "BOOSTING MYELINATION USING VISUAL FLICKER IN THE ACUTE CUPRIZONE INTOXICATION MODEL". The grant, funded under the Military Medical Research and Development program (CFDA 12.420), will support research to investigate medical solutions for the battlefield through basic, applied, and advanced biomedical research. The project is scheduled to be completed...